Preventing the transmission of multidrug-resistant Acinetobacter baumannii: An executive summary of the Association for Professionals in Infection Control and Epidemiology's Elimination Guide

American Journal of Infection Control

Volumn 39, Issue 5, 2011, Pages 439-441

  Rebmann, Terri ^a   Rosenbaum, Patricia A ^b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b NONE

Author keywords

Infection prevention; multi drug resistant organism

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AMBULATORY CARE; BACTERIAL TRANSMISSION; DISEASE SURVEILLANCE; ENVIRONMENTAL SANITATION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LONG TERM CARE; MULTIDRUG RESISTANCE; NEWBORN INTENSIVE CARE; NONHUMAN; PATHOGENESIS; POPULATION; REVIEW; RISK ASSESSMENT;

EID: 79957888422     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.08.015     Document Type: Article

References (11)

1. Centers for Disease Control and Prevention. Overview of drugresistant Acinetobacter infections in healthcare settings. Available at: http://www.cdc.gov/ncidod/dhqp/ar-acinetobacter.html. Accessed July 14, 2010.
2. Falagas ME, Kopterides P, Siempos II. Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis 2006;43:389-91.
3. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2006;35(10 Suppl. 2):S165-93.
4. Rosenbaum P, Aureden K, Cloughessy M, Goss L, Kassai M, Streed SA. Guide to the elimination of multidrug-resistant Acinetobacter baumannii transmission in health care settings. Available from: http:// www.apic.org/AM/Template.cfm? Section=APIC-Elimination-Guides &Template=/CM/HTMLDisplay.cfm&ContentID= 14743. Accessed July 5, 2010.
5. Simmonds A, Munoz J, Aguero-Rosenfeld M, Carbonaro C, Montecalvo M, Clones B, et al. Outbreak of Acinetobacter infection in extremely low birth weight neonates. Pediatr Infect Dis J 2009;28:210-4.
6. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998;36:1938-41. (Pubitemid 28277780)
7. Ayata J, Corbella X, Ardanuy C, Dominguez MA, Ricart A, Ariza J, et al. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 1997;37:287-95. (Pubitemid 28025084)
8. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997;35:1394-7. (Pubitemid 27216802)
9. Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN,Wenzel RP, Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology and antimicrobial susceptibility. Clin Infect Dis 2000;31:690-7. (Pubitemid 32295488)
10. Maragakis LL, Tucker MG, Miller RG, Carroll KC, Perl TM. Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008;299:2513-4. (Pubitemid 351787226)
11. Long SS, Pickering LK, Prober CG. Principles and practice of pediatric infectious diseases. 3rd ed. Philadelphia: Churchill Livingstone Elsevier; 2008.